Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Kewaunee Scientific's Depreciation & Amortization (CF) rose 9602.98% to $1.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.5 million, marking a year-over-year increase of 6875.38%. This contributed to the annual value of $4.8 million for FY2025, which is 5228.8% up from last year.
  • Latest data reveals that Kewaunee Scientific reported Depreciation & Amortization (CF) of $1.6 million as of Q4 2025, which was up 9602.98% from $1.5 million recorded in Q3 2025.
  • Kewaunee Scientific's 5-year Depreciation & Amortization (CF) high stood at $1.6 million for Q4 2025, and its period low was $659000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $725000.0 (2022), whereas its average is $861050.0.
  • In the last 5 years, Kewaunee Scientific's Depreciation & Amortization (CF) plummeted by 618.98% in 2021 and then surged by 9602.98% in 2025.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Depreciation & Amortization (CF) stood at $703000.0 in 2021, then grew by 0.71% to $708000.0 in 2022, then rose by 8.76% to $770000.0 in 2023, then rose by 4.68% to $806000.0 in 2024, then skyrocketed by 96.03% to $1.6 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.6 million in Q4 2025, compared to $1.5 million in Q3 2025 and $806000.0 in Q2 2025.